Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics
about
DNA and protein adducts in human tissues resulting from exposure to tobacco smokeUse of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinicAssociation of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysisMolecular epidemiology of DNA repair gene polymorphisms and head and neck cancer.Inter-individual variation in DNA repair capacity: a need for multi-pathway functional assays to promote translational DNA repair researchGenome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancerSingle nucleotide polymorphisms of DNA mismatch repair genes MSH2 and MLH1 confer susceptibility to esophageal cancerAssociation between single nucleotide polymorphisms in ERCC4 and risk of squamous cell carcinoma of the head and neckA novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neckRole of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: implications for cancer preventionFormation and repair of tobacco carcinogen-derived bulky DNA adductsThe ups and downs of DNA repair biomarkers for PARP inhibitor therapiesDNA repair: from genome maintenance to biomarker and therapeutic target.Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck.Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neckGenetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese populationDNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy.Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study.Apoptotic capacity and risk of squamous cell carcinoma of the head and neck.Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck.Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
P2860
Q27021044-2AB1936A-EAEF-4688-B5A8-A43CDAC16CB6Q28071541-B107B26C-56A7-4E8D-B509-2BB5FCC730D8Q28085418-8B0BAD34-4662-4D95-A953-EE510B280FC4Q28383483-9AA01C75-BD17-46C8-B534-13F65D1A8ABAQ28388726-1C22AF92-74D4-4163-9736-26E872BF0968Q28943482-E8D9A50E-D9D0-4186-AB51-5B0AC254F091Q34167290-9DEE1F6D-57E8-428C-A024-4B20860CE294Q34359175-6B061D8F-54AE-4C98-9CA7-489A5A7A9123Q34363879-17107567-4F19-4FCF-BC7D-80D9A265EEA6Q34402493-76C589DF-D43B-4D6D-AED3-7800B2C8C01EQ34475702-BE586198-1BC5-4A53-85E3-4E35A4D9A0F0Q35232277-11CCCC56-D693-4A80-9A1C-B220DDBB9A2CQ35555880-91F50817-3815-4A7C-A7AD-E340D32A0B32Q35613443-64D8FCD4-F58C-4E26-95AC-0B17141A73E9Q36016570-BD3E3F52-7143-40B6-8555-C71002247A94Q36224270-006CC00A-E262-4833-96C4-AC3E7059C8ADQ36910455-528B49EB-84A9-4F4E-93BE-0B05C76BA21EQ37338205-4FBBCAC9-5C3F-40DD-9094-DDF229315494Q37619227-CEB342F4-9A8D-4A24-AAB6-162024382474Q38151634-0CBF885E-AAF4-4A77-A861-EACF622B66D4Q38811931-44EB6C99-E4C4-4112-8829-DF03A96CEC1AQ40134731-ABDD110F-3FD9-4105-BEF3-4355CACC73F2Q40256963-17B72F93-CF29-4FD8-B766-6D333D0BA42CQ52661245-E3CF9510-9C7E-4787-AB24-CBE5FDD2FB14Q53139678-E190DC0A-0FAE-47DC-A9BB-5753E3A910D2
P2860
Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reduced DNA repair capacity fo ...... but not tumor characteristics
@ast
Reduced DNA repair capacity fo ...... but not tumor characteristics
@en
type
label
Reduced DNA repair capacity fo ...... but not tumor characteristics
@ast
Reduced DNA repair capacity fo ...... but not tumor characteristics
@en
prefLabel
Reduced DNA repair capacity fo ...... but not tumor characteristics
@ast
Reduced DNA repair capacity fo ...... but not tumor characteristics
@en
P2093
P2860
P1476
Reduced DNA repair capacity fo ...... but not tumor characteristics
@en
P2093
Adel K El-Naggar
Ann Marie Gillenwater
Erich M Sturgis
Gary L Clayman
Jeffrey N Myers
Qingyi Wei
Randal S Weber
Sara S Strom
P2860
P304
P356
10.1158/1078-0432.CCR-09-2156
P407
P577
2010-01-12T00:00:00Z